A New Look, New Direction for Society of Nuclear Medicine

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 11 No 8
Volume 11
Issue 8

LOS ANGELES-The Society of Nuclear Medicine (SNM) has changed its logo for the first time in its 49-year history. The new logo is designed to create a bright, fresh look for SNM, Alan Maurer, MD, said at the Society’s 49th Annual Meeting. Dr. Maurer, director of nuclear medicine, Temple University, is the immediate past president of the SNM.

LOS ANGELES—The Society of Nuclear Medicine (SNM) has changed its logo forthe first time in its 49-year history. The new logo is designed to create abright, fresh look for SNM, Alan Maurer, MD, said at the Society’s 49th AnnualMeeting. Dr. Maurer, director of nuclear medicine, Temple University, is theimmediate past president of the SNM.

The new logo retains the roots and heritage of SNM by keeping the atomic orbital symbol. A tagline in the new logo, "advancing molecular imaging," is seen emerging from the atomic orbital. It replaces the caduceus holding the atomic orbital in the old logo.

Although molecular imaging has always been an important part of nuclear medicine, the new tagline identifies the organization as being on the cutting edge of molecular imaging technology, said Michael Gelfand, MD, the new SNM president. "The new logo represents a first step in creating a new and evolving identity for SNM," he said. 

Related Videos
Investigators must continue to explore the space for lisocabtagene maraleucel in mantle cell lymphoma, according to Manali Kamdar, MD.
Those with CML should discuss adverse effects such as nausea or fatigue with their providers to help optimize their quality of life during treatment.
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
Patients with CML can become an active part of their treatment plan by discussing any questions that come to mind with their providers.
A panel of 4 experts on multiple myeloma
Video 1 - 4 KOLs are featured in "Treating Patients Referred to Academic Centers for CAR T"
Video 1 - 4 KOLs are featured in "Identifying Potential Candidates for CAR T-Cell Therapy"
Beth Faiman, CNP, PhD, an expert on multiple myeloma